Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy

PURPOSE: Biomarkers are needed to guide treatment decisions in recurrent ovarian cancer, as a high proportion of patients do not benefit from treatments. Data on immune subsets in patients receiving chemotherapy are scarce. We investigated the impact of T cells, B cells, neutrophils and the neutroph...

Descripción completa

Detalles Bibliográficos
Autores principales: Henriksen, Jon Røikjær, Nederby, Line, Donskov, Frede, Waldstrøm, Marianne, Adimi, Parvin, Jakobsen, Anders, Steffensen, Karina Dahl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229632/
https://www.ncbi.nlm.nih.gov/pubmed/32414391
http://dx.doi.org/10.1186/s13048-020-00661-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229632/
https://www.ncbi.nlm.nih.gov/pubmed/32414391
http://dx.doi.org/10.1186/s13048-020-00661-4

Ejemplares similares